Lucid Diagnostics Inc. (LUCD): 3 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Aug 22, 2025 | Matheis Dennis Director | 100,000 | $1.02 | $102.0K | no history |
| May 23, 2025 | Matheis Dennis Director | 350,000 | $1.31 | $458.3K | no history |
| May 22, 2025 | Matheis Dennis Director | 350,000 | $1.31 | $458.3K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.